Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check7 days agoChange DetectedThe record history shows the page revision updated from v3.5.4 to v3.5.5, indicating a version increment for the page’s history entry. This appears to be a backend/UI update rather than a modification to study data or content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 in the page footer. This indicates a new revision entry for the study record history on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer’s software revision indicator was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without changing the underlying study history shown to users.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history shows the addition of Revision: v3.5.2 and the removal of Revision: v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedNew revision entry v3.5.0 added to the Record History and v3.4.3 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRecord history shows a new revision entry (v3.4.3) and removes the previous revision (v3.4.2).SummaryDifference0.1%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.